These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17139579)

  • 41. Observations on the decay of glycated hemoglobin HbA1c in diabetic patients.
    Rech ME
    Exp Clin Endocrinol Diabetes; 1996; 104(2):102-5. PubMed ID: 8740932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
    Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring study.
    Thomas A; Heinemann L
    J Diabetes Sci Technol; 2012 May; 6(3):572-80. PubMed ID: 22768888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-efficacy affects blood sugar control among adolescents with type I diabetes mellitus.
    Chih AH; Jan CF; Shu SG; Lue BH
    J Formos Med Assoc; 2010 Jul; 109(7):503-10. PubMed ID: 20654789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvement of the compliance with blood glucose monitoring in young insulin-dependent diabetes mellitus patients by the Sensorlink system.
    Dorchy H; Roggemans MP
    Diabetes Res Clin Pract; 1997 May; 36(2):77-82. PubMed ID: 9229191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biological variation of glycation and mean blood glucose have greater influence on Hba1c levels in type 1 young diabetic patients than glucose instability].
    Abourazzak S; Dorchy H; Willems D; Melot C
    Rev Med Brux; 2010; 31(2 Suppl):S55-64. PubMed ID: 21812216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Glucose Control Resistance Scale.
    Nikita ME; Hendy HM; Williams KE; Mueller PL
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):118-124. PubMed ID: 30282617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relation between HbA1c and hypoglycemia revisited; a secondary analysis from an intervention trial in patients with type 1 diabetes and impaired awareness of hypoglycemia.
    van Beers CAJ; Caris MG; DeVries JH; Serné EH
    J Diabetes Complications; 2018 Jan; 32(1):100-103. PubMed ID: 29054335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translating HbA
    Law GR; Gilthorpe MS; Secher AL; Temple R; Bilous R; Mathiesen ER; Murphy HR; Scott EM
    Diabetologia; 2017 Apr; 60(4):618-624. PubMed ID: 28105519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Taori G; Hegarty C; Bailey M
    Crit Care Med; 2011 Jan; 39(1):105-11. PubMed ID: 20975552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
    Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
    BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there a relationship between mean blood glucose and glycated hemoglobin?
    Makris K; Spanou L
    J Diabetes Sci Technol; 2011 Nov; 5(6):1572-83. PubMed ID: 22226280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus.
    Sildorf SM; Hertel NT; Thomsen J; Fredheim S; Hastrup H; Pipper C; Hertz B; Svensson J;
    Diabet Med; 2016 Apr; 33(4):515-22. PubMed ID: 26333180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.